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Abstract 
Background: To analyze the development of 
fundal varices in cirrhotic patients after eradication 
of esophageal varices 
Methods:  In this observational study 150 patients 
of liver cirrhosis, with the history of upper 
gastrointestinal tract bleed and esophageal varices of 
grade F2 and F3 but absence of fundal varices, were 
included. Patients who had previous history of 
banding were excluded.  
Results: Eighty one (54%) patients were male.  
Mean age of the patients was 49.34±11.45 years. 
Twenty two (14.66%) developed fundal varices of 
which 2(1.33%)  patients developed fundal varices at 
2 months, 8(5.33%)  patients developed fundal 
varices at 4 months following banding, and 12(8%) 
patients developed fundal varices at 6 months 
following banding of esophageal varices. Fourteen 
(63.63%) patients had GOV2 while 8(36.36%) had 
IGV1. Conclusion: New fundal varices develop 
with increasing frequency in patients treated with 
esophageal variceal band ligation, and the incidence 
has a time-dependent relationship. 
Key Words:  Fundal Varices,Cirrhosis, Esophageal 
Varices 
 
Introduction 
Liver cirrhosis and liver related diseases are one of the 
frequent causes of hospitalization and a major burden 
on health system. Gastric varices are less prevalent 
than esophageal varices with a higher bleeding 
incidence for fundal varices. Endoscopic variceal band 
ligation is the recommended form of endoscopic 
therapy for esophageal variceal bleeding. New 
incidence of fundal varices is found in 16% of patients 
after eradication of esophageal varices at follow up of 
6 months. Liver cirrhosis is the twelfth leading cause 
of death in USA. Liver cirrhosis and liver related 
diseases are one of the most frequent cause of 
hospitalization in Pakistan and a major burden on 
health system because of its grave complications and 
expenses.1 The most common cause of portal 
hypertension is liver cirrhosis which leads to 
development of gastroesophageal varices with or 
without bleeding, ascites, hepatorenal syndrome, and 
hepatic encephalopathy.2  
Gastroesophageal varices occur in 50% of cirrhotic 
patients at a rate of 10% per year. The clinical course of 
chronic liver disease is complicated by variceal 
hemorrhage in 30% of cases. With each episode of 
variceal bleeding the mortality is 20 - 30%. Around 
70% of survivors have recurrent bleeding after their 
first variceal hemorrhage.3 
Gastric varices are less prevalent than esophageal 
varices and are present in 25% of patients with portal 
hypertension with a higher bleeding incidence for 
fundal varices.4 Secondary gastric varices have a 
significant association with Child-Pugh class, 
presenting grade, increasing number of ligation 
session and prior existence of gastric varices. 5 The 
commonly used classification system introduced by 
Sarin comprises of four types of gastric varices based 
on gastric location and relationship with esophageal 
varices. Gastro-esophageal varices (GOV) either are an 
extension of esophageal varices for 2 to 5 cm along the 
lesser curve of the stomach (GOV1) or extend along 
the greater curve into the fundus (GOV2). 6 Isolated 
gastric varices (IGV) are located either in the fundus 
(IGV1) or in other parts of the stomach (IGV2). GOV1 
account for 74% of all GV, but the incidence of 
bleeding is highest with fundal varices (IGV1 and 
GOV2).4-8 
Endoscopic therapy is recommended in any patient 
who presents with upper GI bleeding. Endoscopic 
variceal band ligation (EVBL) is the recommended 
form of endoscopic therapy for acute esophageal 
variceal bleeding, although sclerotherapy may be used 
in the acute setting if ligation is technically difficult. 
Endoscopic therapy with tissue adhesive (e.g. N-butyl-
cyanoacrylate) is recommended for acute bleeding 
from isolated gastric varices (IGV) and those gastro-
esophageal varices, type 2 (GOV2), that extend beyond 
the cardia. EVBL or tissue adhesive can be used in 
bleeding from gastro esophageal varices type 1 
(GOV1).8,9 
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One local study suggests that new incidence of fundal 
varices is found in 16% of patients after eradication of 
esophageal varices at follow up of 6 months while 
presence of fundal varices at presentation before 
eradication was 7.4%.(5) Another local study suggested 
the presence of fundal varices to be in 3.1% patients at 
presentation for upper GI endoscopy but no follow-up 
after eradication of esophageal varices was done.8 
 
Patients and Methods 
This observational study was conducted at 
Department of Medicine, Aziz Bhatti Shaheed 
Teaching Hospital Gujrat from 15-06-15 to 15-03-17 . 
Sample size was calculated to be 150 patients using 
95% confidence level with 5% margin of error with an 
expected percentage of new fundal varices in 16% of 
patients after band ligation.5 Non-probability 
consecutive sampling method was used and patients 
who had liver cirrhosis with the history of upper GI 
bleed and esophageal varices of grade F2 and F3 but 
absence of fundal varices on endoscopy were included 
in study. Patients who refused to consent and who had 
previous history of banding were excluded from 
study. Severity of liver disease was noted and was 
graded using Child Pugh score. Patients with score of 
5-6 were defined as Child class A, 7-9 as Child Class B 
and 10-15 as Child Class C.  Cirrhosis was defined as 
moderate to severely coarse echotexture of liver on 
abdominal ultrasound. Spleen size, presence of ascities 
and liver span were also noted. The dilated veins 
above the lower esopheageal sphincter found during 
endoscopy were considered as esophageal varices. 
Gastric varices were classified according to 
classification described by Sarin et al.6 Out of gastric 
varices gastroesophageal varices type 2 (GOV2) and 
isolated gastric varices type 1 (IGV1) were considered 
as fundal varices as they are located in fundus of 
stomach.After initial resuscitation, the stabilized 
patients were admitted in the ward. A full history and 
examination was done and the patients were prepared 
for an elective endoscopy list. All baseline 
investigatioons were done and noted and Child Pugh 
Score was calculated. Consent was taken, upper GI 
endoscopy and band ligation was done by the 
consultant gastroenterologist. Performa were filled by 
concerned doctor, and the patients were examined at 
regular interval of two months during study duration 
for a period of 6 months. Those patients who 
developed fundal varices either at second or fourth 
month were not further followed and were included in 
our results. The presence or absence of fundal varices 
and the minimum time to develop fundal varices were 
recorded. All data were entered into a predesigned 
performa. 
Results 
Out of 150 patients, 81 patients (54%) were male and 
remaining 69 patients (46%) were female. Mean age of 
the patients was 49.34±11.45 years. Majority  patients 
(70%) were 41-60 years of age (Table 1) . Only one 
patient (0.6%) was between 81-100 years of age. 55 
patients were Child Class A, 67 Child Class B and 28 
were Child Class C. Mean hemoglobin was 7.62  ± 3.12 
g/dl, mean platelet count was 79 ± 69 x 109/l, mean 
albumin was 3.2 ± 2.1 g/dl and mean bilirubin was 
1.78±1.21 mg/dl. Mean liver size was 12.13 ± 4.34 cm,  
mean spleen size 11.67 ± 3.11 cm and ascities and 
esophageal varices were present in all patients.  F3 
esophageal varices were present in 52.67% patients but 
none of patients had fundal varices (Table 2).  
 
Table 1: Distribution of Patients in Age Groups 
Age (years) No(%) 
20-40 27(18) 
41-60 105(70) 
61-80 17(11) 
 
Table 2: Patient Characteristics 
Total Number of Patients 
(n) 
150 Patients 
Gender -Male: 81 (54%)  
-Female: 69 (46%)  
Mean Age 49.34±11.45 years 
Mean Hemoglobin (g/dl)  7.62  ± 3.12 
Mean Platelet Count 
(109/l) 
79 ± 69  
Mean Albumin (g/dl) 3.2 ± 2.1  
Mean Bilirubin 1.78 ± 1.21  
Mean Liver Size (cm) 12.13 ± 4.34  
Mean Spleen Size (cm) 11.67 ± 3.11 
Ascites 150 (100%) 
Esophageal varices 150 (100%) 
Grades of esophageal 
varices at presentation 
F2 =  71 (47.33%)  
F3 =  79 (52.67%)  
Number of sessions 
required for eradication 
of esophageal varices 
3+2 sessions 
Fundal varices at 
Presentation 
None (0%) 
Child Pugh Class -Child Class A= 55 (36.67%)  
-Child Class B =67 (44.67%) 
-Child Class C= 28 (18.66%)  
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Table 3. Frequency of fundal varix formation 
following esophageal variceal banding 
Follow-Up 
Duration 
Number Percentage GOV2 IGV1 
2 months 2 1.33% 2 0 
4 months 8 5.33% 5 3 
6 months 12 8% 7 5 
Total 22 16% 14 8 
 
Twenty two (14.66%) developed fundal varices. Of 
these 12 patients (8%) developed fundal varices at 6 
months following banding of esophageal varices 
(Table 3). Out of these 22 patients 14(63.63%) had 
GOV2 while 8(36.36%) had IGV1.There was no age co-
relation found (p-value 6.9) with the development of 
fundal varices in patients who were banded for 
esophageal varices.  
Discussion 
Gastric varices are less prevalent than esophageal 
varices and are present in approximately 25% of the 
patients with portal hypertension.4 Eradication of 
esophageal varices has been identified as a risk factor 
for the development of fundal varices. This can be 
explained by the gastric hemodynamic changes that 
result from the blockage of shunting in the palisade 
zone and the formation of “new” or “Secondary” 
gastric varices.5 
Yuksel et al found that 37 out of 85 patients had fundal 
varices before they underwent ligation of esophageal 
varices, increasing to 46 observed at 3 month follow up 
endoscopy after the procedure, a statistically 
significant increment of almost 10.59% after 
eradication. The severity of portal hypertensive 
gastropathy also increased.10  Our study demonstrates 
a higher incidence at six months duration as to this 
study which reflects that formation of fundal varices is 
time dependent. 
In a large reterospective study  by Mumtaz et al. 
comprising 1436 patients, gastric varices were present 
in 220 (15%) patients at presentation. 12 Secondary 
gastric varices were found in 23% of patients within 6 
months after eradication of esophageal varices as 
compared to 14.66% of fundal varices in our study. 
This discrepancy may be due to small sample size in 
this study and that they included all types of gastric 
varices in their as compared to only fundal varices in 
this study. 
Korula et al. in their 7 years follow up of patients 
receiving endoscopic sclerotherapy  for variceal 
hemorrhage found fundal varices in  4.1% cases only. 
13 Method used for bleeding control in their study was 
sclerotherapy as compared of EVBL in this study. 
There is also a difference in sample size and ethnic 
group. 
Available local study has determined that the 
frequency of occurrence of secondary gastric varices 
six months after endoscopic variceal band ligation 
which approximated to 16.04%.5 Our study 
demonstrated a similar result of 14.66% overall 
occurrence of fundal varices following esophageal 
variceal band ligation but in comparison our study has 
established that fundal varices develop as early as 2 
months after band ligation of esophageal varices.  
In another local study by Naseer et al. the frequency of 
fundal varices was found to be 3.1% in patients 
presenting for endoscopy. 8It is much less than our 
results(14.66%). They did not follow the patients after 
eradication of esophageal varices to determine the 
incidence after EVBL which is hallmark of this study. 
The frequency of new fundal varix formation at two 
months was 1.33%, seen in only 2 patients out of a 
hundred and fifty patients being followed. At four 
months of follow up 8 other patients developed fundal 
varices, representing 5.33% of the study population. 
Six months after esophageal variceal band ligation, 
another 12 patients (8%) who had been banded for 
esophageal varices developed fundal varices. Our 
study thus comes as a first in reporting the 
development of new fundal varices in relation to time 
since banding. Therefore, in order to screen for new 
fundal varices, patients must be subjected to an 
endoscopic surveillance program. 
According to our results, the frequency of occurrence, 
and the probability of developing a fundal varix was 
time dependant.  However, there was no predilection 
for the development of fundal varices after esophageal 
variceal band ligation in any particular age group, nor 
does the sex of the patient predispose to increased 
incidence of developing a fundal varix. 
Since limited data exists with regard to the 
development of new fundal varices following 
esophageal banding, there is plenty of space for future 
research, and studies are required with a larger patient 
pool, and with same expert endoscopist for the 
particular period of research. Studies can also be done 
to observe the frequency of formation of fundal varices 
after esophageal banding in comparison with controls, 
and also in patients treated with beta-blockers.      
Conclusion 
1. New fundal varices develop with increasing 
frequency in patients treated with esophageal variceal 
band ligation, and the incidence has a time-dependent 
relationship.  
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